OSE-703

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOSE-703
Drug Alias NameOSE-703
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungMesothelioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOse Immunotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesOse Immunotherapeutics
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungMesothelioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A